Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 899-902

  Chida, Michihiro ^a   Yokoi, Tsuyoshi ^a,d   Fukui, Takafumi ^b   Kinoshita, Moritoshi ^b   Yokota, Jun ^c   Kamataki, Tetsuya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cytochrome P450; PCR RFLP; Polymorphism

Indexed keywords

CYTOCHROME P450 ISOENZYME;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER GENETICS; CANCER SUSCEPTIBILITY; DNA FLANKING REGION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INTRON; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032751791     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00832.x     Document Type: Article

References (18)

1. Butler, M. A., Iwasaki, M., Guengerich, F. P. and Kadlubar, F. F. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA, 86, 7696-7700 (1989).
2. Kamataki, T., Maeda, K., Yamazoe, Y., Matsuda, N., Ishii, K. and Kato, R. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes. Mol. Pharmacol., 24, 146-155 (1983).
3. Yamazoe, Y., Kamataki, T. and Kato, R. Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activation. Cancer Res., 41, 4518-4522 (1981).
4. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C. and Tukey, R. H. Metabolism of 2-acetylaminfluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P-450. Cancer Res., 50, 3367-3376 (1990).
5. Butler, M. A., Lang, N. P., Young, J. F., Caporaso, N. E., Vineis, P., Hayes, R. B., Teitel, C. H., Massengill, J. P., Lawsen, M. F. and Kadlubar, F. F. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics, 2, 116-127 (1992).
6. Sesardic, D., Boobis, A. R., Edwards, R. J. and Davis, D. S. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol., 26, 363-372 (1988).
7. Hammons, G. J., Guengerich, F. P., Weis, C. C., Beland, F. A. and Kadlubar, F. F. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res., 45, 3578-3585 (1985).
8. Minchin, R. F., McManus, M. E., Boobis, A. R., Davies, D. S. and Thorgeirsson, S. S. Polymorphic metabolism of the carcinogen 2-acetylaminofluorene in human liver microsomes. Carcinogenesis, 6, 1721-1724 (1985).
9. Butler, M. A., Guengrich, F. P. and Kadlubar, F. F. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res., 49, 25-31 (1989).
10. Nakajima, M., Yokoi, T., Mizutani, M., Shin, S., Kadlubar, F. F. and Kamataki, T. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol. Biomarkers Prev., 3, 413-421 (1994).
11. Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M. and Kamataki, T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem., 125, 803-808 (1999).
12. Sambrook, J., Fritsch, E. E. and Maniatis, T. "Molecular Cloning: A Laboratory Manual," 2nd Ed., pp. 9-16-9-19 (1989). Cold Spring Harbor Laboratory Press, New York.
13. Quattrochi, L. C. and Tukey, R. H. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol. Pharmacol., 36, 66-71 (1989).
14. Ikeya, K., Jaiswal, A. K., Owens, R. A., Jones, J. E., Nebert, D. W. and Kimura, S. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol. Endocrinol., 3, 1399-1408 (1989).
15. Sesardic, D., Pasanen, M., Pelkonen, O. and Boobis, A. R. Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis, 11, 1183-1188 (1990).
16. Schweikl, H., Taylor, J. A., Kitareewan, T. S., Linko, P., Nagorney, D. and Goldstein, J. A. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics, 3, 239-249 (1993).
17. Kalow, W. and Tang, B. K. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin. Pharmacol. Ther., 49, 44-48 (1991).
18. Sachse, C., Brockmöller, J., Bauer, S. and Roots, I. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol., 47, 445-449 (1999).